Immuron (IMRN) Cash from Operations Growth (1y) (2017 - 2024)
Immuron (IMRN) Cash from Operations Growth (1y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | Immuron | 258.65 Mn | -28.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -40.74% |
| Dec 31, 2023 | -102.00% |
| Jun 30, 2023 | 17.56% |
| Dec 31, 2022 | -69,604.02% |
| Jun 30, 2022 | 22.82% |
| Dec 31, 2021 | 100.05% |
| Jun 30, 2021 | -29.59% |
| Dec 31, 2020 | -73.23% |
| Dec 31, 2019 | -268.06% |
| Dec 31, 2018 | 86.66% |
| Dec 31, 2017 | -303.54% |